Cholesterol retention in Alzheimer's brain is responsible for high β- and γ-secretase activities and Aβ production
- 4 November 2007
- journal article
- research article
- Published by Elsevier BV in Neurobiology of Disease
- Vol. 29 (3), 422-437
- https://doi.org/10.1016/j.nbd.2007.10.005
Abstract
No abstract availableThis publication has 62 references indexed in Scilit:
- PPARγ agonists as new therapeutic agents for the treatment of Alzheimer's diseaseExperimental Neurology, 2006
- The involvement of lipid rafts in Alzheimer's disease (Review)Molecular Membrane Biology, 2006
- Lipids as Modulators of Proteolytic Activity of BACEPublished by Elsevier BV ,2005
- Selective Agonists and Antagonists to Thyroid Hormone ActionThyroid®, 2005
- Protection by cholesterol‐extracting cyclodextrins: a role for N‐methyl‐d‐aspartate receptor redistributionJournal of Neurochemistry, 2005
- A lipid boundary separates APP and secretases and limits amyloid β-peptide generationThe Journal of cell biology, 2004
- Expression and functional characterization of ABCG2 in brain endothelial cells and vesselsThe FASEB Journal, 2003
- Amyloidogenic processing of the Alzheimer β-amyloid precursor protein depends on lipid raftsThe Journal of cell biology, 2003
- Evaluation of multiple presenilin 2 SNPs for association with early‐onset sporadic Alzheimer diseaseAmerican Journal of Medical Genetics, 2002
- Essential role for cholesterol in synaptic plasticity and neuronal degenerationThe FASEB Journal, 2001